TRANSTHERA-B (02617) Selected for Inclusion in Hang Seng Index Series

Stock News
08/25

TRANSTHERA-B (02617) announced that following the quarterly review results published by Hang Seng Indexes Company Limited on August 22, 2025, the company has been selected for inclusion in various Hang Seng index series, effective September 8, 2025.

The company will be included in the following indices: 1. Hang Seng Composite Index; 2. Hang Seng Composite Industry Index - Healthcare; 3. Hang Seng Composite MidCap & SmallCap Index; 4. Hang Seng Composite SmallCap Index; 5. Hang Seng Healthcare Index; 6. Hang Seng Biotech Index; 7. Hang Seng Stock Connect Biotech Index; 8. Hang Seng Stock Connect Biotech Select Index; and 9. Hang Seng Stock Connect Pharmaceuticals & Biotechnology (Investable) Index.

The company stated that its inclusion in the Hang Seng Composite Index and the aforementioned indices reflects rising investor recognition.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10